Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on July 30, 2026

Jul. 30, 2026

Jeen Launches "AI on Your Terms" to Help Enterprise Leaders Ask the Questions Most AI Programmes Skip  

Indeterminate GlobeNewswire

Jul. 30, 2026

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Jul. 30, 2026

Siemens and Tulip Emerge as Leaders as AI in MES Prioritizes Trust, Governance, and Human Oversight

Indeterminate GlobeNewswire

Jul. 30, 2026

HiBob CEO Ronni Zehavi Recognized Among 2026's Top 100 HR Tech Influencers as Organizations Enter the Next Era of Workforce Transformation

Indeterminate GlobeNewswire

Jul. 30, 2026

Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

Indeterminate GlobeNewswire

Jul. 30, 2026

Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Innventure to Announce Second Quarter 2026 Results on August 13, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Diginex Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Jul. 30, 2026

Payabli Brings Intelligence to Every Layer of Embedded Payments

Indeterminate GlobeNewswire

Jul. 30, 2026

Labrynth to Showcase AI-Enabled Permitting Technology at The White House Council on Environmental Quality Permitting Innovators Expo

Indeterminate GlobeNewswire

Jul. 30, 2026

Rocket Doctor Extends EngageWell Partnership to Improve Healthcare Access for Underserved New Yorkers

Indeterminate GlobeNewswire

Jul. 30, 2026

Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Indeterminate GlobeNewswire

Jul. 30, 2026

Aduro Secures Uinta Basin Crude Supply and Completes Continuous-Flow Unit, Advancing Paraffinic Crude Program to Technology Demonstration

Indeterminate GlobeNewswire

Jul. 30, 2026

MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

Indeterminate GlobeNewswire

Jul. 30, 2026

GigaCloud Technology Inc to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire